Quick Takeaways
- Rita Jain has 7 issuer positions tracked on this page.
- Estimated disclosed ownership value: $375,283.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Rita Jain
- Location
- Hampton, NJ
- Summary
- The estimated net worth of Rita Jain is at least $375,283 dollars as of 01 Apr 2026. Rita Jain is the Director of ANAPTYSBIO, INC and owns shares of ANAPTYSBIO, INC (ANAB) stock worth about $359.9K. Rita Jain is the Director of Avalo Therapeutics, Inc. and owns shares of Avalo Therapeutics, Inc. (AVTX) stock worth about $15.4K.
- Signature
- /s/ Rita Jain
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Rita Jain and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: ANAPTYSBIO, INC ($359,910).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Rita Jain
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO, INC | Director | $359,910 | 06 Jan 2026 | ||
| AVTX | Avalo Therapeutics, Inc. | Director | $15,373 | 31 Mar 2026 | ||
| CLDX | Celldex Therapeutics, Inc. | Director | 05 Jun 2025 | |||
| CCXI | ChemoCentryx, Inc. | EVP, Chief Medical Officer, Director | 20 Oct 2022 | |||
| TRAX | First Tracks Biotherapeutics, Inc. | Director | 01 Apr 2026 | |||
| PRVB | Provention Bio, Inc. | Director | 27 Apr 2023 | |||
| SABS, SABSW | SAB Biotherapeutics, Inc. | Director | 05 Jan 2026 |
Insider Transactions Reported by Rita Jain:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.